Hyundai ADM Bio Inc., a contract research organization, provides clinical services in Asia. It offers clinical development services, such as medical writing, clinical operation, late phase study, data management, biostatistics, and regulatory affairs. The company also provides pharmacovigilance services, which include case processing and safety reporting, safety and risk management plans, aggregate reporting, literature screening, and medical device vigilance; and quality assurance services. In addition, it develops, manufactures, and sells medical microneedle patches. The company was formerly known as ADM Korea Inc. and changed its name to Hyundai ADM Bio Inc. in September 2024. Hyundai ADM Bio Inc. was founded in 2003 and is headquartered in Seoul, South Korea.